Prof. Dr. Tunç Fışgın
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
beta-Thalassemia 9 publicationsSource: OpenAlex / PubMed MeSHView publications
- Graft vs Host Disease 6 publications
- Anemia, Iron-Deficiency 4 publications
- COVID-19 3 publications
- Severe Combined Immunodeficiency 3 publications
- Invasive Fungal Infections 2 publications
- Leukemia 2 publications
- Cytomegalovirus Infections 2 publications
- Neoplasms 2 publications
- Purpura, Thrombocytopenic, Idiopathic 2 publications
- Nephrotic Syndrome 2 publications
- Hematologic Diseases 2 publications
- Fanconi Anemia 2 publications
- Thrombocytopenia 2 publications
- Thrombasthenia 2 publications
- Seizures 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.
- Kemik iliği nakli
- Kök hücre tedavisi
- Aferez
CV
Education and experience
Experience
- Experience2002 – 2005 Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Dr. Öğr. Üyesi, Samsunmedicalpark.com.tr
- Experience2003 Ankara Üniversitesi Tıp Fakültesi Çocuk Kemik İliği Nakil Ünitesi, Ankaramedicalpark.com.tr
- Experience2003 Cincinnati Childrens Hospital Pediatric Bone Marrow Transplantation Unit, Cincinnati, USAmedicalpark.com.tr
- Experience2005 – 2011 Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Doçent Doktor, Öğretim Üyesi, Samsunmedicalpark.com.tr
- Experience2009 – 2011 Ondokuz Mayıs Üniversitesi Tıp Fakültesi, Sadettin Vasfi Baysal Çocuk Kemik İliği Nakil Ünitesi Direktörlüğü, Samsunmedicalpark.com.tr
- Experience2011 – 2013 VM Medical Park Samsun Çocuk Kemik İliği Nakil Ünitesi Direktörlüğümedicalpark.com.tr
- Experience2013 Bahçeşehir Üniversitesi Tıp Fakültesi, Prof. Dr, Öğretim Üyesi, İstanbulmedicalpark.com.tr
- Experience2014 Medical Park Bahçelievler, Çocuk Kemik İliği Nakil Ünitesi Direktörlüğü, İstanbulmedicalpark.com.tr
- Experience2017 Medical Park Bahçelievler, Medikal Direktörmedicalpark.com.tr
Education
- 19861992 Uludağ Üniversitesi Tıp Fakültesi, Tıp Eğitimi, Bursamedicalpark.com.tr
- Education1992 – 1995 Kurtlar Sağlık Ocağı, Ereğli, Zonguldakmedicalpark.com.tr
- Education1995 – 1999 Dr. Sami Ulus Çocuk Hastanesi, Çocuk Sağlığı ve Hastalıkları Uzmanlık Eğitimi, Ankaramedicalpark.com.tr
- Education1999 – 2002 Dr.Sami Ulus Çocuk Hastanesi Çocuk Hematoloji Bölümü, Çocuk Hematoloji Uzmanlık Eğitimi, Ankaramedicalpark.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyPaediatric Haematology and Oncologymedicalpark.com.trFrom source
- Institutionİstinye Üniversitesi Gaziosmanpaşa Hastanesimedicalpark.com.trFrom source
- Area of workbeta-ThalassemiaExtracted from 9 publications · Model version —From source
- Publications101 publicationsOpenAlex, ORCIDFrom source
- ORCID0000-0003-4467-9935ORCIDFrom source
- Last synchronised4 November 2026 20:30https://www.medicalpark.com.tr/hekimler/tunc-fisginmedicalpark.com.tr
Scientific work
Publications on beta-Thalassemia
-
Impact of clinical pharmacist-led medication management and education on tacrolimus therapeutic control
Frontiers in Medicine, 2026
DOI 10.3389/fmed.2026.1851388 PMID 42344490 1 citation (OpenAlex) Open-access full textSource: OpenAlex
-
Antimicrobial Lock Therapy: Is it a Real Savior in Pediatric Hematopoetic Stem Cell Transplant (HSCT) Patients?
Turkish Journal of Hematology, 2025
DOI 10.4274/tjh.galenos.2025.2025.0189 PMID 40643209 Open-access full textSource: OpenAlex
-
Early Relapse with Isolated Myeloid Sarcoma in a Patient Diagnosed Acute Myeloid Leukemia with FLT3- D835Y Mutation
SN Comprehensive Clinical Medicine, 2025
DOI 10.1007/s42399-025-01954-9 Source: OpenAlex
-
TÜRKİYE’DEKİ NADİR KALITSAL HEMOLİTİK ANEMİLERİN FENOTİP- GENOTİP DEĞERLENDİRMESİ
Erciyes University - AVESIS, 2025
Source: OpenAlex
-
Evaluating the Antibiofilm Effects of Antibiotics on Staphylococcus Species from Pediatric Hematology–Oncology Patients
Microbial Drug Resistance, 2025
DOI 10.1089/mdr.2025.0006 PMID 40340597 2 citations (OpenAlex) Source: OpenAlex
-
Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells
Biomolecules, 2025
DOI 10.3390/biom15091245 PMID 41008552 2 citations (OpenAlex) Open-access full textSource: OpenAlex
-
COVID‐19 disease in children and adolescents following allogeneic hematopoietic stem cell transplantation: A report from the Turkish pediatric bone marrow transplantation study group
Pediatric Transplantation, 2024
DOI 10.1111/petr.14758 PMID 38659218 Open-access full textSource: OpenAlex
-
Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: How Do Anti‐HLA Antibodies Impact?
Clinical Transplantation, 2024
DOI 10.1111/ctr.70035 PMID 39601247 Open-access full textSource: OpenAlex
-
Antimicrobial Lock Therapy: Is it a real savior in pediatric hematopoetic stem cell transplant (HSCT) patients?
2024
DOI 10.21203/rs.3.rs-4540053/v1 Open-access full textSource: ORCID
-
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity.
Blood, 2024
DOI 10.1182/blood.2024024038 PMID 38669631 21 citations (Europe PMC) Open-access full textSource: ORCID